MedPath

Comparison of Botulinum Toxin and Sphincterotomy in the Treatment of Chronic Anal Fissure

Completed
Conditions
Pain
Interventions
Procedure: conservative lateral internal sphincterotomy
Procedure: Intra-sphincteric Botulinum-toxin injection
Registration Number
NCT01095900
Lead Sponsor
Theodor Bilharz Research Institute
Brief Summary

Intra-sphincteric injection of botulinum toxin seems to be a reliable option causing temporary alleviation of sphincter spasm and allowing the fissure to heal. study is to compare the outcome of surgical sphincterotomy and botulinum toxin injection treatments in patients with uncomplicated chronic anal fissure.

Detailed Description

consecutive patients with uncomplicated chronic anal fissure who had failed conservative treatment were randomized to receive either intra-sphincteric injection of botulinum toxin (BT) or lateral internal sphincterotomy (LIS). Postoperative pain relief, healing of fissure, continence scores and fissure relapse during 18 weeks of follow up was the outcomes assessed.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • The diagnosis of chronic anal fissure was based on evidence of circumscribed ulcer at anal canal with indurations at the edges and exposure of the horizontal fibers of the internal anal sphincter at its floor.
Exclusion Criteria
  • Anal fissure that had been operated on before, complicated fissure with cicatricial deformation, large sentinel pile, associated hemorrhoids, suspected inflammatory bowel disease, or malignancy.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
LIS group)conservative lateral internal sphincterotomy-
BT groupIntra-sphincteric Botulinum-toxin injection-
Primary Outcome Measures
NameTimeMethod
Postoperative pain relief, healing of fissure, continence scores18 weeks
Secondary Outcome Measures
NameTimeMethod
fissure relapse18 weeks

Trial Locations

Locations (1)

Department of General Surgery-Theodore Bilharz Research Institute ,

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath